Literature DB >> 34776439

Research Advances in the Treatment of Alzheimer's Disease with Polysaccharides of Danggui-Shaoyao-San.

Xin Fu1, Qiantong Liu1, Xiaowei Sun1, Hui Chang1,2, Ying Liu1, Jiatong Han1.   

Abstract

Alzheimer's disease (AD) is a common progressive neurodegenerative disease. In recent years, the research on the treatment of AD with Chinese medicine is increasing and the results are optimistic, which may provide some new options for the treatment of AD. Existing animal and clinical studies have found that Danggui Shaoyao San (DSS), which has been used in gynecological diseases, is effective in the treatment of AD. As the main component of DSS, macromolecular polysaccharide plays an indispensable role in the treatment of AD. In addition to anti-inflammatory, anti-neuronal injury, and immune regulation, polysaccharides extracted from Danggui Shaoyao San (p-DSS) also have good activities in hypoglycemia, and participate in the physiological regulation of ubiquitination, iron metabolism, intestinal flora, estrogen, and autophagy. Given that there is little systematic analysis of p-DSS, this paper reviews the possible mechanism of p-DSS in the treatment of AD, so as to provide reference for further research.

Entities:  

Keywords:  Alzheimer’s disease; estrogens; hypoglycemic; intestinal flora; iron metabolism; polysaccharides of Danggui-Shaoyao-San

Mesh:

Substances:

Year:  2022        PMID: 34776439     DOI: 10.3233/JAD-210656

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  1 in total

1.  Using network pharmacology to explore the mechanism of Danggui-Shaoyao-San in the treatment of diabetic kidney disease.

Authors:  Jinfei Yang; Chenrui Li; Yan Liu; Yachun Han; Hao Zhao; Shilu Luo; Chanyue Zhao; Na Jiang; Ming Yang; Lin Sun
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.